MedTrace Logo

Effect of NWT-03 on Blood Pressure

NCT02144740 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2014-05-23

No results posted yet for this study

Summary

Part 2 of the study will assess the effect of 2g of NWT-03 (an egg-white protein hydrolysate) on systolic and diastolic blood pressure and flow-mediated dilation in a crossover designed study in healthy adults with mild hypertension.

Conditions

Interventions

DIETARY_SUPPLEMENT

NWT-03, an egg-white protein hydrolysate

For placebo comparator, a combination of sweetener + aroma, which was equal to the combination used in the intervention period, was given

DIETARY_SUPPLEMENT

Placebo

A combination of sweetener + aroma , which was equal to the combination used in the intervention period, was given.

Sponsors & Collaborators

  • Newtricious R&D BV

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-04-30

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02144740 on ClinicalTrials.gov